Current Treatment Options in Rheumatology, Journal Year: 2025, Volume and Issue: 11(1)
Published: March 11, 2025
Language: Английский
Current Treatment Options in Rheumatology, Journal Year: 2025, Volume and Issue: 11(1)
Published: March 11, 2025
Language: Английский
Postgraduate Medicine, Journal Year: 2024, Volume and Issue: 136(4), P. 406 - 416
Published: May 16, 2024
This study sought to investigate the relationship between systemic inflammatory response index (SIRI) and bone mineral density (BMD), osteoporosis, future fracture risk in elderly hypertensive patients.
Language: Английский
Citations
27Polymers, Journal Year: 2023, Volume and Issue: 15(16), P. 3354 - 3354
Published: Aug. 10, 2023
With the success of several clinical trials products based on human serum albumin (HSA) and rapid development nanotechnology, HSA-based nanodrug delivery systems (HBNDSs) have received extensive attention in field nanomedicine. However, there is still a lack comprehensive reviews exploring broader scope HBNDSs biomedical applications beyond cancer therapy. To address this gap, review takes systematic approach. Firstly, it focuses crystal structure potential binding sites HSA. Additionally, provides summary recent progresses for various over past five years, categorized according to type therapeutic drugs loaded onto These categories include small-molecule drugs, inorganic materials bioactive ingredients. Finally, summarizes characteristics current application status drug delivery, also discusses challenges that need be addressed transformation HSA formulations offers future perspectives field.
Language: Английский
Citations
32Nature Reviews Rheumatology, Journal Year: 2024, Volume and Issue: 20(7), P. 417 - 431
Published: June 3, 2024
Language: Английский
Citations
14Archives of Pharmacal Research, Journal Year: 2024, Volume and Issue: 47(4), P. 301 - 324
Published: April 1, 2024
Language: Английский
Citations
13International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 271, P. 132442 - 132442
Published: May 16, 2024
Language: Английский
Citations
12Clinical Rheumatology, Journal Year: 2024, Volume and Issue: 43(5), P. 1421 - 1433
Published: March 18, 2024
Language: Английский
Citations
10Annals of the Rheumatic Diseases, Journal Year: 2024, Volume and Issue: 84(2), P. 201 - 209
Published: Aug. 26, 2024
Language: Английский
Citations
10Experimental Gerontology, Journal Year: 2025, Volume and Issue: 203, P. 112729 - 112729
Published: March 11, 2025
Rheumatoid arthritis (RA) promotes the onset and progression of sarcopenia, yet mechanisms co-morbidity between RA sarcopenia are under-explored. Therefore, this study integrated Gene Expression Omnibus (GEO) Genome-wide association studies (GWAS) data to comprehensively identify shared genes, associated mechanisms, biological pathways in sarcopenia. Utilizing two GEO datasets-GSE226151, which includes 60 RNA-seq samples skeletal muscle from healthy aged, pre-sarcopenia, individuals, GSE55235, with 20 synovial tissue joints-we performed differentially expressed genes analysis, weighted gene co-expression network analysis crosstalk enrichment for these genes. Using relevant GWAS datasets, SMR analyses cis-eQTL were performed. We further validated identified key explored potential causal associations sarcopenia-related traits. 25 involved immune-inflammatory response pathways, including neutrophil extracellular trap formation Fc gamma receptor-mediated phagocytosis. six core genes: NCF1, FCGR2A, FCGR3A, SORL1, FCGR3B, ITGAX (PSMR < 0.05). showed that FCGR2A might have a negative appendicular lean mass, whole body fat-free positive (P Overall, is first reveal molecular identifying response-related pathways. Further conducted validate emerging as drug target RA-associated These findings provide new insights into comorbid offering therapeutic targets both conditions.
Language: Английский
Citations
1PLoS ONE, Journal Year: 2025, Volume and Issue: 20(3), P. e0320079 - e0320079
Published: March 19, 2025
Physical functioning refers to the ability perform daily living activities, namely basic instrumental, and advanced activities. Poorer performance in these areas may indicate potential presence of sarcopenia. To analyze differences physical function between older people with without sarcopenia investigate associations tests A cross-sectional study based on data from Northern region Brazil year 2018 was conducted. Study participants included 312 aged ≥ 60 years (64.1% female). Sarcopenia defined using updated criteria European Working Group Older People (EWGSOP2). measured functional fitness (30-second chair stand test, sit-and-reach 8-foot Up-and-Go Test, 6-minute walk 4-meter gait speed, Fullerton Advanced Balance Scale). Confirmed detected 29.2% participants, but no participant had severe Most parameters crude analysis were associated confirmed (all p < 0.05), except for back scratch test. In a model adjusted sex, age body mass index, slower speed (OR = 1.29, 95%CI 1.08 1.54), up-and-go test time 1.32, 1.16 1.49), greater 0.97, 0.94 0.99) higher self-reported Composite Function scores 0.94, 0.89 significantly status. EWGSOP2 is prevalent residing Brazil's independently walking rising ability, reduced trunk lower-limb flexibility, as well poorer function.
Language: Английский
Citations
1Clinical Rheumatology, Journal Year: 2024, Volume and Issue: 43(6), P. 1865 - 1870
Published: April 26, 2024
Language: Английский
Citations
7